Anemia Treatment Drugs Market Insights, Global Outlook and Forecast 2022-2028
Anemia Treatment Drugs Market Insights, Global Outlook and Forecast 2022-2028
The Anemia Treatment Drugs study provides a comprehensive overview of safety standards, market penetration, and innovation pipelines across major economies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Anemia is a condition in which you don't have enough healthy red blood cells to carry adequate oxygen to the body's tissues.
The latest research study released by Market IntelliX evaluates market size and forecasts of Anemia Treatment Drugs in Global, including the following market information:
Global Anemia Treatment Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Anemia Treatment Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Supplements Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anemia Treatment Drugs include Pfizer, Inc., Amgen, Inc., Hoffmann-La Roche Ltd., Merck Sharp & Dohme Corp., Novartis AG, Janssen Pharmaceutical, Bayer AG, AMAG Pharmaceuticals and GlaxoSmithKline plc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Anemia Treatment Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Anemia Treatment Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Anemia Treatment Drugs Market Segment Percentages, by Type, 2021 (%)
Supplements
Antibiotics
Immunosuppressant
Bone Marrow Stimulants
Corticosteroids
Gene Therapy
Iron Chelating Agents
Global Anemia Treatment Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Anemia Treatment Drugs Market Segment Percentages, by Application, 2021 (%)
Iron deficiency anemia
Thalassemia
Aplastic anemia
Hemolytic anemia
Sickle cell anemia
Pernicious anemia
Global Anemia Treatment Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Anemia Treatment Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anemia Treatment Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Anemia Treatment Drugs revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Pfizer, Inc.
Amgen, Inc.
Hoffmann-La Roche Ltd.
Merck Sharp & Dohme Corp.
Novartis AG
Janssen Pharmaceutical
Bayer AG
AMAG Pharmaceuticals
GlaxoSmithKline plc
Akebia Therapeutics
Vifor Pharma Management, Ltd.
FibroGen, Inc.
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Anemia Treatment Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anemia Treatment Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anemia Treatment Drugs Overall Market Size
2.1 Global Anemia Treatment Drugs Market Size: 2021 VS 2028
2.2 Global Anemia Treatment Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anemia Treatment Drugs Players in Global Market
3.2 Top Global Anemia Treatment Drugs Companies Ranked by Revenue
3.3 Global Anemia Treatment Drugs Revenue by Companies
3.4 Top 3 and Top 5 Anemia Treatment Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Anemia Treatment Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anemia Treatment Drugs Players in Global Market
3.6.1 List of Global Tier 1 Anemia Treatment Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Anemia Treatment Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Anemia Treatment Drugs Market Size Markets, 2021 & 2028
4.1.2 Supplements
4.1.3 Antibiotics
4.1.4 Immunosuppressant
4.1.5 Bone Marrow Stimulants
4.1.6 Corticosteroids
4.1.7 Gene Therapy
4.1.8 Iron Chelating Agents
4.2 By Type - Global Anemia Treatment Drugs Revenue & Forecasts
4.2.1 By Type - Global Anemia Treatment Drugs Revenue, 2017-2022
4.2.2 By Type - Global Anemia Treatment Drugs Revenue, 2023-2028
4.2.3 By Type - Global Anemia Treatment Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anemia Treatment Drugs Market Size, 2021 & 2028
5.1.2 Iron deficiency anemia
5.1.3 Thalassemia
5.1.4 Aplastic anemia
5.1.5 Hemolytic anemia
5.1.6 Sickle cell anemia
5.1.7 Pernicious anemia
5.2 By Application - Global Anemia Treatment Drugs Revenue & Forecasts
5.2.1 By Application - Global Anemia Treatment Drugs Revenue, 2017-2022
5.2.2 By Application - Global Anemia Treatment Drugs Revenue, 2023-2028
5.2.3 By Application - Global Anemia Treatment Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Anemia Treatment Drugs Market Size, 2021 & 2028
6.2 By Region - Global Anemia Treatment Drugs Revenue & Forecasts
6.2.1 By Region - Global Anemia Treatment Drugs Revenue, 2017-2022
6.2.2 By Region - Global Anemia Treatment Drugs Revenue, 2023-2028
6.2.3 By Region - Global Anemia Treatment Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Anemia Treatment Drugs Revenue, 2017-2028
6.3.2 US Anemia Treatment Drugs Market Size, 2017-2028
6.3.3 Canada Anemia Treatment Drugs Market Size, 2017-2028
6.3.4 Mexico Anemia Treatment Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Anemia Treatment Drugs Revenue, 2017-2028
6.4.2 Germany Anemia Treatment Drugs Market Size, 2017-2028
6.4.3 France Anemia Treatment Drugs Market Size, 2017-2028
6.4.4 U.K. Anemia Treatment Drugs Market Size, 2017-2028
6.4.5 Italy Anemia Treatment Drugs Market Size, 2017-2028
6.4.6 Russia Anemia Treatment Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Anemia Treatment Drugs Market Size, 2017-2028
6.4.8 Benelux Anemia Treatment Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Anemia Treatment Drugs Revenue, 2017-2028
6.5.2 China Anemia Treatment Drugs Market Size, 2017-2028
6.5.3 Japan Anemia Treatment Drugs Market Size, 2017-2028
6.5.4 South Korea Anemia Treatment Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Anemia Treatment Drugs Market Size, 2017-2028
6.5.6 India Anemia Treatment Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Anemia Treatment Drugs Revenue, 2017-2028
6.6.2 Brazil Anemia Treatment Drugs Market Size, 2017-2028
6.6.3 Argentina Anemia Treatment Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Anemia Treatment Drugs Revenue, 2017-2028
6.7.2 Turkey Anemia Treatment Drugs Market Size, 2017-2028
6.7.3 Israel Anemia Treatment Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Anemia Treatment Drugs Market Size, 2017-2028
6.7.5 UAE Anemia Treatment Drugs Market Size, 2017-2028
7 Players Profiles
7.1 Pfizer, Inc.
7.1.1 Pfizer, Inc. Corporate Summary
7.1.2 Pfizer, Inc. Business Overview
7.1.3 Pfizer, Inc. Anemia Treatment Drugs Major Product Offerings
7.1.4 Pfizer, Inc. Anemia Treatment Drugs Revenue in Global Market (2017-2022)
7.1.5 Pfizer, Inc. Key News
7.2 Amgen, Inc.
7.2.1 Amgen, Inc. Corporate Summary
7.2.2 Amgen, Inc. Business Overview
7.2.3 Amgen, Inc. Anemia Treatment Drugs Major Product Offerings
7.2.4 Amgen, Inc. Anemia Treatment Drugs Revenue in Global Market (2017-2022)
7.2.5 Amgen, Inc. Key News
7.3 Hoffmann-La Roche Ltd.
7.3.1 Hoffmann-La Roche Ltd. Corporate Summary
7.3.2 Hoffmann-La Roche Ltd. Business Overview
7.3.3 Hoffmann-La Roche Ltd. Anemia Treatment Drugs Major Product Offerings
7.3.4 Hoffmann-La Roche Ltd. Anemia Treatment Drugs Revenue in Global Market (2017-2022)
7.3.5 Hoffmann-La Roche Ltd. Key News
7.4 Merck Sharp & Dohme Corp.
7.4.1 Merck Sharp & Dohme Corp. Corporate Summary
7.4.2 Merck Sharp & Dohme Corp. Business Overview
7.4.3 Merck Sharp & Dohme Corp. Anemia Treatment Drugs Major Product Offerings
7.4.4 Merck Sharp & Dohme Corp. Anemia Treatment Drugs Revenue in Global Market (2017-2022)
7.4.5 Merck Sharp & Dohme Corp. Key News
7.5 Novartis AG
7.5.1 Novartis AG Corporate Summary
7.5.2 Novartis AG Business Overview
7.5.3 Novartis AG Anemia Treatment Drugs Major Product Offerings
7.5.4 Novartis AG Anemia Treatment Drugs Revenue in Global Market (2017-2022)
7.5.5 Novartis AG Key News
7.6 Janssen Pharmaceutical
7.6.1 Janssen Pharmaceutical Corporate Summary
7.6.2 Janssen Pharmaceutical Business Overview
7.6.3 Janssen Pharmaceutical Anemia Treatment Drugs Major Product Offerings
7.6.4 Janssen Pharmaceutical Anemia Treatment Drugs Revenue in Global Market (2017-2022)
7.6.5 Janssen Pharmaceutical Key News
7.7 Bayer AG
7.7.1 Bayer AG Corporate Summary
7.7.2 Bayer AG Business Overview
7.7.3 Bayer AG Anemia Treatment Drugs Major Product Offerings
7.7.4 Bayer AG Anemia Treatment Drugs Revenue in Global Market (2017-2022)
7.7.5 Bayer AG Key News
7.8 AMAG Pharmaceuticals
7.8.1 AMAG Pharmaceuticals Corporate Summary
7.8.2 AMAG Pharmaceuticals Business Overview
7.8.3 AMAG Pharmaceuticals Anemia Treatment Drugs Major Product Offerings
7.8.4 AMAG Pharmaceuticals Anemia Treatment Drugs Revenue in Global Market (2017-2022)
7.8.5 AMAG Pharmaceuticals Key News
7.9 GlaxoSmithKline plc
7.9.1 GlaxoSmithKline plc Corporate Summary
7.9.2 GlaxoSmithKline plc Business Overview
7.9.3 GlaxoSmithKline plc Anemia Treatment Drugs Major Product Offerings
7.9.4 GlaxoSmithKline plc Anemia Treatment Drugs Revenue in Global Market (2017-2022)
7.9.5 GlaxoSmithKline plc Key News
7.10 Akebia Therapeutics
7.10.1 Akebia Therapeutics Corporate Summary
7.10.2 Akebia Therapeutics Business Overview
7.10.3 Akebia Therapeutics Anemia Treatment Drugs Major Product Offerings
7.10.4 Akebia Therapeutics Anemia Treatment Drugs Revenue in Global Market (2017-2022)
7.10.5 Akebia Therapeutics Key News
7.11 Vifor Pharma Management, Ltd.
7.11.1 Vifor Pharma Management, Ltd. Corporate Summary
7.11.2 Vifor Pharma Management, Ltd. Business Overview
7.11.3 Vifor Pharma Management, Ltd. Anemia Treatment Drugs Major Product Offerings
7.11.4 Vifor Pharma Management, Ltd. Anemia Treatment Drugs Revenue in Global Market (2017-2022)
7.11.5 Vifor Pharma Management, Ltd. Key News
7.12 FibroGen, Inc.
7.12.1 FibroGen, Inc. Corporate Summary
7.12.2 FibroGen, Inc. Business Overview
7.12.3 FibroGen, Inc. Anemia Treatment Drugs Major Product Offerings
7.12.4 FibroGen, Inc. Anemia Treatment Drugs Revenue in Global Market (2017-2022)
7.12.5 FibroGen, Inc. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Research Methodology:
Anemia Treatment Drugs Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|